LINEAGE CELL THERAPEUTICS IN's ticker is LCTX and the CUSIP is 53566P109. A total of 101 filers reported holding LINEAGE CELL THERAPEUTICS IN in Q2 2022. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,103 | +350.3% | 1,402,123 | +251.4% | 0.00% | – |
| Q4 2022 | $467 | -99.9% | 399,039 | -21.2% | 0.00% | – |
| Q3 2022 | $572,000 | -64.5% | 506,313 | -50.4% | 0.00% | -100.0% |
| Q2 2022 | $1,612,000 | +486.2% | 1,020,446 | +471.7% | 0.00% | – |
| Q1 2022 | $275,000 | -66.3% | 178,493 | -46.4% | 0.00% | – |
| Q4 2021 | $816,000 | +1565.3% | 333,220 | +1615.4% | 0.00% | – |
| Q3 2021 | $49,000 | -98.5% | 19,425 | -98.6% | 0.00% | -100.0% |
| Q1 2021 | $3,351,000 | +437.0% | 1,425,776 | +301.9% | 0.00% | – |
| Q4 2020 | $624,000 | +86.3% | 354,753 | -0.8% | 0.00% | – |
| Q3 2020 | $335,000 | +2691.7% | 357,528 | +2417.8% | 0.00% | – |
| Q2 2020 | $12,000 | – | 14,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 4,735,990 | $8,335,000 | 3.63% |
| BROADWOOD CAPITAL INC | 34,005,379 | $59,849,000 | 3.55% |
| Prescott General Partners LLC | 1,851,851 | $3,259,000 | 0.14% |
| Strategic Wealth Investment Group, LLC | 66,917 | $118,000 | 0.07% |
| Laidlaw Wealth Management LLC | 170,658 | $300,000 | 0.06% |
| Humankind Investments LLC | 26,737 | $47,000 | 0.05% |
| DAFNA Capital Management LLC | 80,000 | $141,000 | 0.04% |
| Beirne Wealth Consulting Services, LLC | 45,000 | $79,000 | 0.04% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 680,839 | $1,198,000 | 0.02% |
| Allegheny Financial Group LTD | 20,000 | $35,000 | 0.02% |